Archaeologists recently found a massive stone basin in Italy dating back more than 2,000 years — remnants of a once-powerful rival of Rome. The discovery was found in the ancient ruins of Gabii, about ...
Archaeologists recently found a massive stone basin in Italy dating back more than 2,000 years — remnants of a once-powerful rival of Rome. The discovery was found in the ancient ruins of Gabii, about ...
College students continue to report poor mental health, with more than one in three students saying they experience moderate anxiety or depression. Data from the most recent Healthy Minds Survey, ...
ORLANDO, Florida, Aug 27 (Reuters) - There is legitimate debate about the actual independence of modern-day central banks, but almost everyone agrees that overt politicization of monetary policy – as ...
A new biography by Susana M. Morris reveals the struggles, passions and triumphs that shaped the science fiction icon and her books. By Dana A. Williams Dana A. Williams is a professor of African ...
NEW YORK, July 25 (Reuters Breakingviews) - Buyout shops learned some hard lessons this week. The initial public offerings for educational publisher McGraw Hill (MH.N), opens new tab and market ...
Singapore-based AI startup Sapient Intelligence has developed a new AI architecture that can match, and in some cases vastly outperform, large language models (LLMs) on complex reasoning tasks, all ...
This Pew Research Center analysis focuses on public opinion of China in 25 countries across the Asia-Pacific region, Europe, Latin America, the Middle East-North Africa region, North America and ...
Four-day school weeks don’t appear to benefit students much, if at all, according to a new report from University of Oregon researchers. The report comes from a review of 11 studies of four-day school ...
Improved self-esteem and motivation. Positive discipline encourages children through clear expectations combined with emotional support, fostering intrinsic motivation—so children act responsibly ...
Lyell Immunopharma, Inc. announced promising clinical data for its CAR T-cell therapy candidate LYL314, showing an 88% overall response rate and a 72% complete response rate in patients with relapsed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback